The incidence of new-onset secondary atrial fibrillation (NOSAF) is as high as 44% in noncardiac critical illness. A systematic review and meta-analysis were performed to evaluate the impact of NOSAF,…
Distal radial artery access (DRA) is recommended as the preferred approach over the traditional proximal radial artery access (TRA) for coronary procedures; however, there are limited randomized controlled trials (RCTs)…
The optimal timing of coronary artery bypass grafting (CABG) in patients after an acute myocardial infarction (MI) is unknown. We performed a systematic review and meta-analysis of studies comparing mortality…
Recently, one observational study showed that patients with ST-segment elevation myocardial infarction (STEMI) without standard cardiovascular risk factors were associated with increased mortality compared with patients with risk factors. This…
Highlights • Layered plaque, an optical coherence tomography equivalent of healed plaque, has been gaining attention. • Burden of plaque layer in relation to layered plaque characteristics was evaluated. •…
Exercise stress testing is routinely performed to evaluate suspected coronary artery disease in older adults. However, the available data to predict and compare relative exercise capacity in the general population…
Highlights • Many patients with ST-elevation myocardial infarction still develop heart failure. • Incident heart failure significantly increases mortality. • Well-established predictors only explain a small fraction of that risk….
Acute myocardial infarction (AMI)–related mortality has been decreasing within the United States because of improvements in management and preventive efforts; however, persistent disparities in demographic subsets such as race may…
Angina is a common symptom in patients with coronary artery disease (CAD); however, its impact on patients’ quality of life over time is not well understood. We sought to determine…
Clinical trials have demonstrated cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). However, their impact on all-cause and cause-specific hospitalization in real-world practice remains…
